# Genesis Life Sciences Fund LP — Form D

Genesis Life Sciences Fund LP of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-30. $14.3M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2012-03-30
- Form: D
- Accession: 0000898432-12-000417
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.1
- Amount sold: $14.3M
- Minimum investment: $250K
- Investors: 29
- Date of first sale: 2010-10-15
- SEC file number: 021-175941

## Issuer

- Name: Genesis Life Sciences Fund LP
- CIK: 0001545731
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 1212 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Phone: 212-798-1360

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Ethan E Benovitz | Executive Officer | New York, NY |
| Jaime J Hartman | Executive Officer | New York, NY |
| Daniel J Saks | Executive Officer | New York, NY |

## More

- [CIK 1545731 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1545731&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000898432-12-000417.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.